DrugPatentWatch Database Preview
Try a free trialSee Plans and Pricing
« Back to Dashboard
Midazolamis the generic ingredient in six branded drugs marketed by Ucb Inc, Akorn Inc, Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, West-ward Pharms Int, Wockhardt, Mylan Asi, HLR, Meridian Medcl Techn, Hi Tech Pharma, Paddock Llc, Pd Partners, Sun Pharm Inds Ltd, and Roche, and is included in thirty-eight NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are nine drug master file entries for midazolam. One supplier is listed for this compound. There are three tentative approvals for this compound.
Summary for midazolam
Pharmacology for midazolam
|Drug Class||Benzodiazepine |
Synonyms for midazolam
|4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate|
|DEA No. 2884|
|Midazolam 0.1 mg/ml in Methanol|
|Midazolam 1.0 mg/ml in Methanol|
|Midazolam hydrochloride, solid|
|Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard|
|Midazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material|
Generic filers with tentative approvals for MIDAZOLAM
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Make Better Decisions: Try a trial or see plans & pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.